United Kingdom
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 6.57 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
2 |
USD 501.70 M
|
Dec. 31, 2023 | USD 5.03 | -1.57% |
|
United Kingdom |
|
3 |
USD 14.38 M
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
4 |
USD 10.80 M
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
5 |
USD 9.96 M
|
Dec. 31, 2023 | USD 5.68 | 0.09% |
|
United Kingdom |
|
6 |
USD 6.46 M
|
June 30, 2024 | USD 17.38 | -3.70% |
|
United Kingdom |
|
7 |
USD 6.24 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
8 |
USD 5.06 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
9 |
USD 177.00 K
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
10 |
USD -570.34 K
|
Nov. 30, 2023 | USD 0.03 | 0.09% |
|
United Kingdom |
|
11 |
USD -844.83 K
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
12 |
USD -913.53 K
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
13 |
USD -1.11 M
|
Dec. 31, 2023 | USD 0.05 | 0.09% |
|
United Kingdom |
|
14 |
USD -1.33 M
|
Dec. 31, 2023 | USD 0.13 | -2.30% |
|
United Kingdom |
|
15 |
USD -1.74 M
|
Dec. 31, 2023 | USD 0.04 | -14.59% |
|
United Kingdom |
|
16 |
USD -1.75 M
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
17 |
USD -1.94 M
|
Dec. 31, 2023 | USD 0.21 | 0.09% |
|
United Kingdom |
|
18 |
USD -2.11 M
|
Dec. 31, 2023 | USD 0.02 | 2.68% |
|
United Kingdom |
|
19 |
USD -2.15 M
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
20 |
USD -2.23 M
|
March 31, 2024 | USD 0.11 | -6.40% |
|
United Kingdom |
|
21 |
USD -2.27 M
|
Dec. 31, 2023 | USD 0.04 | -9.47% |
|
United Kingdom |
|
22 |
USD -2.48 M
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
23 |
USD -2.57 M
|
Sept. 30, 2024 | USD 0.36 | 3.24% |
|
United Kingdom |
|
24 |
USD -2.73 M
|
May 31, 2024 | USD 0.24 | -4.72% |
|
United Kingdom |
|
25 |
USD -2.95 M
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
26 |
USD -3.58 M
|
June 30, 2024 | USD 0.31 | 0.09% |
|
United Kingdom |
|
27 |
USD -3.70 M
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
|
28 |
USD -4.81 M
|
June 30, 2024 | USD 0.03 | -4.36% |
|
United Kingdom |
|
29 |
USD -4.96 M
|
June 30, 2024 | USD 0.27 | 2.36% |
|
United Kingdom |
|
30 |
USD -6.36 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
31 |
USD -7.39 M
|
Dec. 31, 2023 | USD 0.05 | -16.59% |
|
United Kingdom |
|
32 |
USD -7.41 M
|
March 31, 2024 | USD 2.29 | -3.78% |
|
United Kingdom |
|
33 |
USD -7.62 M
|
Dec. 31, 2023 | USD 0.71 | 0.09% |
|
United Kingdom |
|
34 |
USD -7.92 M
|
Dec. 31, 2023 | USD 4.80 | 0.73% |
|
United Kingdom |
|
35 |
USD -8.03 M
|
Dec. 31, 2023 | USD 0.20 | 0.09% |
|
United Kingdom |
|
36 |
USD -8.65 M
|
Aug. 31, 2023 | USD 0.16 | -0.68% |
|
United Kingdom |
|
37 |
USD -9.02 M
|
Dec. 31, 2023 | USD 4.18 | -2.79% |
|
United Kingdom |
|
38 |
USD -9.49 M
|
March 31, 2024 | USD 1.03 | NA |
|
United Kingdom |
|
39 |
USD -9.60 M
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
40 |
USD -9.76 M
|
Dec. 31, 2023 | USD 15.26 | 0.09% |
|
United Kingdom |
|
41 |
USD -10.56 M
|
Dec. 31, 2023 | USD 0.03 | -2.14% |
|
United Kingdom |
|
42 |
USD -10.99 M
|
Sept. 30, 2023 | USD 0.01 | -33.27% |
|
United Kingdom |
|
43 |
USD -19.24 M
|
Dec. 31, 2023 | USD 0.14 | 0.09% |
|
United Kingdom |
|
44 |
USD -19.78 M
|
April 30, 2024 | USD 0.11 | -4.08% |
|
United Kingdom |
|
45 |
USD -20.53 M
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
46 |
USD -21.55 M
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
47 |
USD -29.52 M
|
Dec. 31, 2023 | USD 0.23 | 1.46% |
|
United Kingdom |
|
48 |
USD -34.25 M
|
Dec. 31, 2023 | USD 1.04 | 1.96% |
|
United Kingdom |
|
49 |
USD -44.98 M
|
June 30, 2024 | USD 0.09 | 2.54% |
|
United Kingdom |
|
50 |
USD -48.79 M
|
Dec. 31, 2023 | USD 4.79 | -4.31% |
|
United Kingdom |
The Biotechnology company in United Kingdom with the highest Free Cash Flow is AstraZeneca PLC (LSE: AZN.L) at USD 6.57 B.
The Biotechnology company in United Kingdom with the lowest Free Cash Flow is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD -766.65 M.
The top 10 Biotechnology companies in United Kingdom by Free Cash Flow are AstraZeneca PLC, Clarivate Plc, NIOX Group Plc, Bioventix PLC, Science Group plc, Genus plc, ECO Animal Health Group plc, SDI Group plc, Tissue Regenix Group plc and Light Science Technologies Holdings Plc.
The bottom 10 Biotechnology companies in United Kingdom by Free Cash Flow are Roivant Sciences Ltd., Oxford Nanopore Technologies plc, Autolus Therapeutics plc, Bicycle Therapeutics plc, Barinthus Biotherapeutics plc, Verona Pharma plc, Silence Therapeutics plc, Oxford Biomedica plc, Allergy Therapeutics plc and NuCana plc.